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IMPACT OF GAIN-OF-FUNCTION MUTATIONS IN THE LOW DENSITY LIPOPROTEIN 
RECEPTOR RELATED PROTEIN 5 (LRP5) ON GLUCOSE AND LIPID HOMEOSTASIS. Dinah Foer, 
Meiling Zhu, Christine Simpson, Grace Lee, Rebecca Sullivan, and Karl L. Insogna. Section of 
Endocrinology, Department of Internal Medicine, Yale University, School of Medicine, New Haven, CT.   
Investigations in animal models suggest a physiologic link between LRP5 and glucose and lipid 
homeostasis. However, the data in human studies is far from consensus. While LRP5 has been shown to be 
critical to Wnt signaling, the molecular mechanism for the effect on metabolism is unknown. We 
hypothesize that a high bone mass (HBM) mutation in LRP5 will lead to improved glucose and lipid 
homeostasis. We aim to measure the impact of these mutated receptors on human glucose and lipid 
metabolism and to investigate the pathway(s) by which Wnt may affect glucose metabolism in vitro. 
Eleven subjects with HBM-causing LRP5 mutations were matched by gender, age, and body mass index 
(BMI) to 22 unrelated control subjects. Hemoglobin A1c (HbA1c), estimated average glucose (eAG), 
HOMA-B, HOMA-IR, and lipid panel were analyzed. An oral glucose tolerance test and 1HMRS study of 
liver and skeletal muscle were performed on a subset of affected patients. Primary hepatocytes and HepG2 
cells were treated in vitro with Wnt3a, and PEPCK-C mRNA expression was measured by QPCR. INS-1 
cells and human pancreatic islet beta-cells were assayed for glucose-stimulated insulin secretion using an 
ELISA technique. Statistical differences were analyzed using the unpaired Student t-test and one-way 
ANOVA. There were no statistically significant differences between affected and control populations for 
HbA1c, eAG, insulin, HOMA-B and HOMA-IR. Differences in total cholesterol, triglycerides, and HDL, 
were not significant. However, LDL levels were significantly lower in affected subjects (p=0.04). Wnt did 
not effect PEPCK-C expression. Wnt did not significantly effect glucose-stimulated insulin secretion in 
INS-1 cells and human islets. In summary, this is the first investigation on the metabolic consequences of 
LRP5 mutations in human kindreds with HBM-causing mutations. Our data does not support the hypothesis 
that LRP5 improves glucose metabolism in these individuals. The data does suggest that there may be a 
specific, beneficial effect of LRP5 on LDL cholesterol, however additional studies need to be done to 




























































































































































































































HOMA[B)1*! g171v! 22.3! 6.4! 137! 5.5! 1.9! 26.8!2! g171v! 20.8! 5.6! 114! 8.0! 2.3! 56.5!3! g171v! 35.0! 8.2! 188.6! 14.9! 6.9! 42.7!4! g171v! 34.0! 5.2! 102.5! 17.8! 4.5! 162.2!5! g171v! 29.4! 5.6! 114! 10.6! 3.0! 74.8!6! g171v! 24.8! 5.4! 108.3! 9.9! 2.7! 78.7!7! g171v! 32.7! 5.9! 122.6! 24.4! 7.4! 147.4!8! g171v! 26.7! 5.5! 111.2! 5.8! 1.6! 43.3!9*! g171v! 34.7! 6.8! 148.5! 12.1! 4.4! 51.0!10! n198s! 21.2! 5.7! 116.9! 12.4! 3.6! 82.8!11! n198s! 20.1! 5.4! 108.3! 7.0! 1.9! 55.6!
























































(mg/dL))2! 20.8! 115! 49! 40! 65.2!4! 34.0! 180! 112! 58! 99.6!6! 24.8! 185! 66! 71! 100.8!7! 32.7! 163! 104! 45! 97.2!8! 26.7! 149! 44! 68! 72.2!9! 34.7! 143! 140! 49! 66.0!10! 21.2! 209! 132! 101! 81.6!11! 20.1! 212! 96! 80! 112.8!
Mean±SEM& 26.9±2.2& 169.5±11.8& 92.9±12.9& 64.0±7.2& 86.9±6.4&
A!Genotypes!as!listed!in!Table!3.!B!!Study!subjects!#1,!#3,!#5!were!excluded!for!reasons!described!in!text.!C!LDL=TC)HDL)(TG/5)!(Friedewald!et!al.,!1972).!!
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!
Figure)4A.)Comparison)of)total)blood)cholesterol)in)affected)and)control)
individuals)
)
!Individuals!taking!lipid!lowering!drugs!were!excluded!from!the!analysis.!Total!cholesterol!levels!were!not!significantly!different!(p=0.43).!Data!is!shown!as!mean±SEM.!
)
)
Figure)4B.!Comparison)of)blood)triglyceride)levels)in)affected)and)control)
individuals)!
!!Individuals!taking!lipid!lowering!drugs!were!excluded!from!the!analysis.!Triglyceride!levels!were!not!significantly!different!(p=0.56).!Data!is!shown!as!mean±SEM.!
)
)
)
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Figure)4C.!Comparison)of)high)density)lipoprotein)(HDL))level)in)affected)and)
control)individuals)!
!!Individuals!taking!lipid!lowering!drugs!were!excluded!from!the!analysis..!HDL!levels!were!not!significantly!different!(p=0.32).!Data!is!shown!as!mean±SEM.!
)
)
Figure)4D.)Comparison)of)low)density)lipoprotein)(LDL))levels)in)affected)and)
control)individuals)
)
!!Individuals!taking!lipid!lowering!drugs!were!excluded!from!the!analysis.!LDL!levels!were!significantly!lower!in!affected!individuals!(p=0.04).!Data!is!shown!as!mean±SEM.!!!!!!!
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Figure)5.)Relative)expression)of)LRP5)in)rat)tissues)
)
!!LRP5!expression!was!highest!in!the!liver,!and!lowest!in!bone.!Transcript!expression!is!defined!as!fold!change!in!comparison!to!liver.!!!
Figure)6A.)Regulation)of)PEPCK[C)expression)in)primary)rat)hepatocytes)by)
insulin)
)
!
)Phosphoenolpyruvate!carboxykinase!(cytosolic!form)!(PEPCK)C)!expression!in!primary!rat!hepatocytes!was!measured!in!the!presence!of!known!inducers!and!inhibitors!to!confirm!the!sensitivity!of!our!in&vitro!assay.!Insulin!predictably!suppressed!PEPCK)C!expression!compared!to!the!control!(p=0.02).!Data!is!shown!as!mean±SEM.!!!!!
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Figure)6B.)Regulation)of)PEPCK[C)expression)in)primary)rat)hepatocytes)by)
dexamethasone))!
!!PEPCK)C!expression!in!primary!rat!hepatocytes!was!measured!in!the!presence!of!known!inducers!and!inhibitors!to!confirm!the!sensitivity!of!our!in&vitro!assay.!Dexamethasone!predictably!induced!PEPCK)C!expression!compared!to!the!control!(p=0.05).!Data!is!shown!as!mean±SEM.!
)
)
Figure)6C.)Regulation)of)PEPCK[C)expression)in)primary)rat)hepatocytes)by)
glucagon,)insulin)and)dexamethasone)!
!!PEPCK)C!expression!in!primary!rat!hepatocytes!was!measured!in!the!presence!of!known!inducers!and!inhibitors!to!confirm!the!sensitivity!of!our!in&vitro!assay.!Glucagon!predictably!induced!PEPCK)C!expression!compared!to!the!control.!This!experiment!confirmed!the!induction!of!PEPCK)C!by!dexamethasone,!and!its!
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suppression!by!insulin!relative!to!control.!The!effect!of!glucagon!was!blunted!by!insulin!(p=0.01).!Data!analyzed!using!one)way!ANOVA.!Data!is!shown!as!mean±SEM.!!!
Figure)7A.)Effect)of)Wnt)on)PEPCK[C)expression)in)primary)rat)hepatocytes))
)
!!PEPCK)C!levels!were!measured!after!treatment!for!24!hours!with!100ng/ml!of!Wnt.!Wnt!had!no!effect!on!PEPCK)C!transcript!expression!(p=0.42).!Data!is!shown!as!mean±SEM.!!!
Figure)7B.))Effect)of)Wnt)and)Dexamethasone[induced)expression)of)PEPCK[C))
in)primary)rat)hepatocytes))
)
!
)PEPCK)C!transcript!levels!were!measured!after!treatment!with!Wnt!or!Wnt!in!combination!Dexamethasone.!Dexamethasone!alone!induced!PEPCK)C!expression.!The!addition!of!Wnt!did!not!significantly!change!the!effect!of!dexamethasone!(p=0.42).!Data!is!shown!as!mean±SEM.!
)
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Figure)7C.!Effect)of)Wnt)and)glucagon)on)PEPCK[C)expression)in)primary)rat)
hepatocytes))
)
!!PEPCK)C!levels!were!measured!in!after!treatment!with!Wnt!or!in!combination!with!glucagon.!Glucagon!alone!induced!PEPCK)C!expression.!The!addition!of!Wnt!did!not!significantly!alter!the!response!to!glucagon!(p=0.90).!Data!is!shown!as!mean±SEM.!!!
Figure)8.)The)effect)of)Wnt)on)glucose[induced)insulin)secretion)in)INS[1)cells))
)
!!INS)1!cells!were!treated!with!Wnt!in!the!presence!of!basal!(2.5mM)!and!stimulatory!(9.0!mM)!levels!of!glucose)!High!extracellular!glucose!significantly!increased!insulin!secretion.!However,!the!addition!of!Wnt!did!not!change!basal!or!glucose)stimulated!insulin!secretion.!Data!is!shown!as!mean±SEM.!!!!!!
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Figure)9.)LRP5)transcript)expression)in)INS[1)cells)and)primary)rat)islets.))
)
!LRP5!transcript!expression!in!the!INS)1!cells!was!compared!to!that!in!primary!rat!islets.!LRP5!expression!in!INS)1!cells!was!less!than!half!of!that!in!the!primary!rat!islets.!!!!
Figure)10.)Effect)of)Wnt)on)glucose[induced)insulin)release)from)primary)
human)islets)
)
!!Human!islets!were!perifused!with!Wnt!and!exposed!to!basal!(2.5mM)!and!stimulatory!(9.0mM)!concentrations!of!glucose.!Glucose)induced!insulin!secretion!was!not!affected!by!Wnt!treatment.!!!!!!!!!
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